Calcium in PDB 5i96: Crystal Structure of Human Mitochondrial Isocitrate Dehydrogenase (IDH2) R140Q Mutant Homodimer in Complex with Ag-221 (Enasidenib) Inhibitor.

Enzymatic activity of Crystal Structure of Human Mitochondrial Isocitrate Dehydrogenase (IDH2) R140Q Mutant Homodimer in Complex with Ag-221 (Enasidenib) Inhibitor.

All present enzymatic activity of Crystal Structure of Human Mitochondrial Isocitrate Dehydrogenase (IDH2) R140Q Mutant Homodimer in Complex with Ag-221 (Enasidenib) Inhibitor.:
1.1.1.42;

Protein crystallography data

The structure of Crystal Structure of Human Mitochondrial Isocitrate Dehydrogenase (IDH2) R140Q Mutant Homodimer in Complex with Ag-221 (Enasidenib) Inhibitor., PDB code: 5i96 was solved by W.Wei, B.Zhang, L.Jin, F.Jiang, B.Delabarre, J.A.Travins, A.K.Padyana, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

*Resolution Low / High (Å)*	41.90 / 1.55
*Space group*	P 2₁ 2₁ 2₁
*Cell size a, b, c (Å), α, β, γ (°)*	58.368, 120.348, 124.734, 90.00, 90.00, 90.00
*R / R_free (%)*	16.3 / 19.9

Other elements in 5i96:

The structure of Crystal Structure of Human Mitochondrial Isocitrate Dehydrogenase (IDH2) R140Q Mutant Homodimer in Complex with Ag-221 (Enasidenib) Inhibitor. also contains other interesting chemical elements:

Fluorine	(F)	12 atoms
Sodium	(Na)	2 atoms

Calcium Binding Sites:

The binding sites of Calcium atom in the Crystal Structure of Human Mitochondrial Isocitrate Dehydrogenase (IDH2) R140Q Mutant Homodimer in Complex with Ag-221 (Enasidenib) Inhibitor. (pdb code 5i96). This binding sites where shown within 5.0 Angstroms radius around Calcium atom.
In total 2 binding sites of Calcium where determined in the Crystal Structure of Human Mitochondrial Isocitrate Dehydrogenase (IDH2) R140Q Mutant Homodimer in Complex with Ag-221 (Enasidenib) Inhibitor., PDB code: 5i96:
Jump to Calcium binding site number: 1; 2;

Calcium binding site 1 out of 2 in 5i96

Go back to

Calcium Binding Sites List in 5i96

Calcium binding site 1 out of 2 in the Crystal Structure of Human Mitochondrial Isocitrate Dehydrogenase (IDH2) R140Q Mutant Homodimer in Complex with Ag-221 (Enasidenib) Inhibitor.

Mono view

Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 1 of Crystal Structure of Human Mitochondrial Isocitrate Dehydrogenase (IDH2) R140Q Mutant Homodimer in Complex with Ag-221 (Enasidenib) Inhibitor. within 5.0Å range:

probe	atom	residue	distance (Å)	B	Occ
A:Ca501 b:14.5 occ:0.78	O	A:HOH830	2.3	25.4	1.0
	OD1	A:ASP314	2.3	14.7	1.0
	O	A:HOH605	2.4	23.7	1.0
	OD2	B:ASP291	2.4	19.9	1.0
	O	A:HOH603	2.5	24.2	0.6
	OG	A:SER317	2.5	21.0	0.7
	O	A:HOH932	2.5	30.8	1.0
	O	A:ASP314	2.6	14.8	1.0
	CG	A:ASP314	3.4	13.1	1.0
	CG	B:ASP291	3.5	17.6	1.0
	C	A:ASP314	3.5	15.1	1.0
	CB	A:SER317	3.5	22.6	0.7
	CB	A:SER317	4.0	25.3	0.3
	OD2	A:ASP318	4.0	24.3	0.3
	CA	A:ASP314	4.1	10.8	1.0
	CB	B:ASP291	4.1	18.2	1.0
	OD2	A:ASP314	4.1	12.8	1.0
	CB	A:ASP314	4.3	10.6	1.0
	O	A:HOH1027	4.4	36.4	1.0
	O	A:HOH609	4.4	36.7	1.0
	N	A:VAL315	4.4	11.4	0.7
	OD1	B:ASP291	4.5	16.7	1.0
	CA	A:VAL315	4.5	10.6	0.7
	N	A:SER317	4.5	14.0	0.7
	O	A:HOH735	4.6	36.1	1.0
	N	A:VAL315	4.6	10.8	0.3
	OG	A:SER317	4.6	26.6	0.3
	NZ	B:LYS251	4.6	12.8	1.0
	CA	A:SER317	4.6	18.7	0.7
	CG	A:ASP318	4.8	27.9	0.3
	C	A:VAL315	4.9	12.3	0.7

Calcium binding site 2 out of 2 in 5i96

Go back to

Calcium Binding Sites List in 5i96

Calcium binding site 2 out of 2 in the Crystal Structure of Human Mitochondrial Isocitrate Dehydrogenase (IDH2) R140Q Mutant Homodimer in Complex with Ag-221 (Enasidenib) Inhibitor.

Mono view

Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 2 of Crystal Structure of Human Mitochondrial Isocitrate Dehydrogenase (IDH2) R140Q Mutant Homodimer in Complex with Ag-221 (Enasidenib) Inhibitor. within 5.0Å range:

probe	atom	residue	distance (Å)	B	Occ
A:Ca509 b:16.8 occ:0.80	OD1	B:ASP318	2.2	23.4	0.6
	OD1	B:ASP314	2.2	15.9	0.6
	O	B:HOH782	2.3	30.4	1.0
	OD2	A:ASP291	2.4	20.9	1.0
	O	B:HOH705	2.4	31.9	1.0
	OD1	B:ASP314	2.4	14.3	0.4
	O	B:HOH720	2.5	30.8	1.0
	O	B:ASP314	2.9	12.7	0.4
	O	B:ASP314	3.0	16.1	0.6
	OD1	B:ASP318	3.1	30.1	0.4
	OD2	B:ASP318	3.2	30.1	0.4
	CG	B:ASP314	3.3	14.3	0.4
	CG	B:ASP318	3.3	32.8	0.6
	CG	B:ASP314	3.4	14.2	0.6
	CG	A:ASP291	3.4	25.9	1.0
	CG	B:ASP318	3.5	29.5	0.4
	C	B:ASP314	3.6	11.7	0.4
	C	B:ASP314	3.8	14.4	0.6
	OD2	B:ASP314	3.8	14.3	0.4
	OD2	B:ASP318	3.9	34.1	0.6
	CB	A:ASP291	3.9	21.3	1.0
	OD2	B:ASP314	4.1	13.7	0.6
	CA	B:ASP314	4.2	11.0	0.4
	CA	B:ASP314	4.2	11.7	0.6
	CB	B:ASP314	4.3	12.1	0.4
	CB	B:ASP314	4.4	9.4	0.6
	N	B:VAL315	4.4	12.8	0.4
	OD1	A:ASP291	4.5	18.6	1.0
	CA	B:VAL315	4.5	9.4	0.4
	O	B:HOH711	4.5	40.9	1.0
	CB	B:ASP318	4.6	29.0	0.6
	NZ	A:LYS251	4.7	14.4	1.0
	N	B:VAL315	4.9	9.3	0.6
	C	B:VAL315	5.0	11.4	0.4
	CB	B:SER317	5.0	21.7	0.4
	O	B:HOH726	5.0	18.1	1.0
	N	B:ASP318	5.0	17.7	0.6

Reference:

K.Yen, J.Travins, F.Wang, M.D.David, E.Artin, K.Straley, A.Padyana, S.Gross, B.Delabarre, E.Tobin, Y.Chen, R.Nagaraja, S.Choe, L.Jin, Z.Konteatis, G.Cianchetta, J.O.Saunders, F.G.Salituro, C.Quivoron, P.Opolon, O.Bawa, V.Saada, A.Paci, S.Broutin, O.A.Bernard, S.De Botton, B.S.Marteyn, M.Pilichowska, Y.Xu, C.Fang, F.Jiang, W.Wei, S.Jin, L.Silverman, W.Liu, H.Yang, L.Dang, M.Dorsch, V.Penard-Lacronique, S.A.Biller, S.M.Su. Ag-221, A First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations. Cancer Discov V. 7 478 2017.
ISSN: ESSN 2159-8290
PubMed: 28193778
DOI: 10.1158/2159-8290.CD-16-1034

Page generated: Sun Jul 14 20:28:06 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW

	© Copyright 2008-2020 by atomistry.com
Home \| Site Map \| Copyright \| Contact us \| Privacy